Although the common mucosal immune system has generally been considered to have only short-term memory, recent data suggest that long-term memory exists for Shigella virulence plasmid antigens. Because such antigens might cross-react with environmental antigens, we investigated milk for the persistence of antibodies to the specific Shigella lipopolysaccharide (LPS) antigens. Enzyme-linked immunosorbent assays to detect secretory immunoglobulin A (sIgA) against Shigella flexneri and Shigella sonnei LPS in milk samples were developed; 15 random milk samples tested on different days correlated from one day to the next (P = 0.0001). Of 18 Mexican mothers, 18 (100%) had one or more milk samples positive for anti-S.flexneri LPS, 14 (78%) had one or more milk samples positive for anti-S. sonnei LPS, and 14 (78%) had one or more milk samples positive for both. Of 27 Houston mothers, 16 (59%) had one or more milk samples positive for anti-S. flexneri LPS, 7 (26%) had one or more milk samples positive for anti-S. sonnei LPS, and 5 (19%) had one or more milk samples positive for both. Mexican mothers were significantly more likely than Houston mothers to have at least one sample with a positive titer for anti-S. flexneri LPS (P < 0.002) and at least one sample with a positive titer for anti-S. sonnei LPS (P < 0.002). Although the Houston women had a lower rate of titer positivity for both Shigella species, the rate was too high to be consistent with short-lived mucosal immunity. It is unlikely that 18 of the 27 Houston women had shigellosis during or just prior to lactation. The data suggest that there exists a long-term hormonally driven memory in the secretory immune system for Shigella spp.
Shigella spp. and other enteric pathogens are major causes of morbidity and mortality in infants and young children, especially in developing countries. Breastfeeding appears to play an important role in protecting infants from symptomatic gastrointestinal infections. Several studies have shown that the number and severity of Shigella infections (7, 19, 25, 26, 41) are decreased in children who are breastfed compared with those who are formula fed. Information gained by studying the mechanisms by which human milk protects against infection with Shigella spp. and other enteric pathogens may be useful in designing and evaluating future Shigella vaccines.
To date, the exact mechanisms by which breastfeeding is protective remain unclear. In addition to providing the infant with an uncontaminated source of nutrition, breast milk contains phagocytic cells (neutrophils and macrophages), B cells, T cells, specific antibodies, and nonspecific cell receptor analogs that react with bacterial virulence factors (4, 12, 32, 33, 36, 37, 40, 43) .
In breast milk, the presence of secretory immunoglobulin A (sIgA) antibodies directed against specific enteric pathogens has been shown and is thought to be a result of the migration of gut-derived lymphocytes to the mammary tissues (28) (29) (30) (31) 40) . It is not known exactly how the mammary tissue preferentially attracts IgA-producing B cells (31) . The migration of IgA-producing plasma cells and the synthesis of sIgA in the mammary gland are governed by the hormones of pregnancy and lactation (34) .
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antibody excretion in human milk over the course of lactation have not been extensively studied. Previous studies have documented that human milk sometimes contains sIgA to Shigella LPS (1, 11, 21) . Little is known about the timing of primed lymphocyte migration to the mammary tissues or the duration of memory for these cells. We, therefore, evaluated serial milk samples of women from two populations of differing Shigella incidence for sIgA antibodies directed against the LPS of Shigellaflexneri and the LPS of Shigella sonnei to gain some insight into the dynamics of the secretory immune system as it relates to anti-S. flexneri LPS, r = 0.88, P < 0.01; for anti-S. sonnei LPS, r = 0.98, P < 0.02).
Comparison of anti-Shigella LPS positivity of Mexican and Houston women. Of the 18 women from Mexico, 18 (100%) had at least one milk sample positive for sIgA against S. flexneri LPS, 14 (78%) had at least one milk sample positive for sIgA against S. sonnei LPS, and 14 (78%) had one or more milk samples positive for both. Of the 27 women from Houston, 16 (59%) had at least one milk sample positive for sIgA against S. flexneri LPS, 7 (26%) had at least one milk sample positive for sIgA against S. sonnei LPS, and 5 (19%) had one or more milk samples positive for both. When these data were compared by using contingency table analysis, it was found that Mexican women were significantly more likely than Houston women to have at least one milk sample with a positive titer for anti-S. flexneri LPS (P < 0.002), and the same was true for anti-S. sonnei LPS antibodies (P < 0.002) ( Table 1) . Four of 18 (22%) Mexican women and 13 of 27 (48%) Houston women had milk samples which were positive for sIgA antibodies against one but not the other Shigella LPS. Evaluation of sIgA titers over lactation time. Titers of colostrum ranged from 0 to 1:1,280 for anti-S. flexneri LPS and 0 to 1:5,120 for anti-S. sonnei LPS; titers of mature milk ranged from 0 to 1:640 for anti-S. flexneri LPS and from 0 to 1:320 for anti-S. sonnei LPS for all women who did not report diarrhea during lactation. The geometric mean titers of all available milk samples from women who did not report diarrhea during lactation are plotted against days of lactation in Fig. 1 and 2 . There were women from both Mexico and Houston who showed persistently positive titers for anti-S. flexneri LPS or anti-S. sonnei LPS as late as the eighth month of lactation. In the Houston population where reinfection with Shigella spp. during lactation is generally a rare event, 10 of 18 (56%) women who had positive titers for either anti-S. flexneri LPS, anti-S. sonnei LPS, or both, continued to have persistently positive titers throughout the course of lactation (as late as day 247), demonstrating presumably hormonally driven antibody secretion. In general, most Houston women (23 of 27 or 85%) did not develop significant increases in anti-S. sonnei LPS or anti-S. flexneri LPS titers throughout the course of lactation; however, a dramatic exception was seen in a Houston woman who had an illness thought to be shigellosis. Her titers for sIgA against S. sonnei LPS rose from 1:20 early in lactation to 1:5,120 on day 94 and remained persistently elevated at .1:640 for the remainder of lactation; she reported that she had diarrhea and fever for 3 days at the end of the second month of lactation, but no stool culture had been performed within 4 weeks after infection, but the duration of antiShigella LPS antibody positivity was not extensively evaluated in his group of 17 adult Swedish patients (35) . In one study of 97 adult and pediatric patients with S. flexneri infection in Hanoi, Vietnam, children 1 to 2 years of age were found to have elevated serum IgA titers against S. flexneri LPS up to 60 days after falling ill (14) . In a study of 14 Swedish adults with S. flexneri dysentery, 79% (11 of 14) responded with positive serum IgA titers against S. flexneri LPS within 4 weeks of the onset of infection and as many as 56% showed persistently positive IgA titers at 1 year postinfection (16) . Serum studies of IgA directed against the virulence plasmid-associated antigens have also been done. In a study of 41 Thai adults and children, 8 of 19 children and 1 of 22 adults were shown to develop IgA antibodies against virulence plasmid-associated antigen 3 to 4 weeks after acute shigellosis (13) . Thus, it is apparent that the serum IgA response to Shigella infection is immediate, peaks at 2 to 4 weeks after infection, and drops to low levels within 2.5 months.
Studies of anti-Shigella antibodies in stool have been carried out by using Western blotting and dot blotting techniques. In one study, increases in fecal IgA against S. flexneri water extracts and S. sonnei LPS were seen after 5 days of illness (45) . Long-term studies evaluating antiShigella sIgA in human stool samples have not been reported. Animal data, however, indicate that the local sIgA response in the intestinal tract is not persistent. In rabbit ileal loop studies, sIgA levels initially increased but then decreased or dropped to baseline within 24 to 32 days after challenge with various Shigella species (22, 23) .
Evaluations of human colostrum and breast milk for IgA antibodies against Shigella spp. have also been done. In 1982, Cruz et al. showed that women from differing populations (Sweden and Guatemala) had comparable quantities of milk antibodies to Escherichia coli (pool of eight somatic E. coli antigens) (10) . However, in 1985, the same investigators studied anti-Shigella LPS antibodies in the milk of women from the same two geographic areas and found that the concentrations of IgA differed among Swedish, rural and urban poor Guatemalan, and privileged Guatemalan women (11) . We have likewise found population-based differences in sIgA antibody titers in breast milk samples.
In this study, we developed two ELISAs which were shown to be reliable and reproducible in measuring anti-S.
flexneri LPS and anti-S. sonnei LPS sIgA titers. There was no cross-reaction between antibodies against S. flexneri LPS and S. sonnei LPS. This was expected, given the structural dissimilarities for both the 0-repeat units and core oligosaccharides produced by these organisms (2, 3, 20, 24, 39) . The fact that several women had antibodies to one but not the other LPS and the fact that the sample which was the Western-blot-proven positive control for the S. flexneri LPS ELISA was also the negative control for the S. sonnei LPS ELISA suggest that the antibodies measured were specific and were made to the specific O side chains of the LPS molecule rather than a shared lipid A component.
The data for individual women are consistent with the concept that when an acute Shigella infection occurs during lactation, the sIgA titers of breast milk may rise and persist. In cases where such acute increases in specific antibody are seen, the response may represent either initial exposure to the antigen or an amnestic response triggered by reexposure to a previously recognized antigen. The most dramatic example of this is the history of diarrhea and fever in one of the Houston women during lactation, with a subsequently (17, 18) . There is no source for repeated antigenic stimulation in the community to boost antibody titers as there is for polio or for the choleralike toxins of Campylobacter spp., Salmonella spp., or E. coli. Therefore, most of the Houston women with positive titers were presumably manifesting a hormonally driven, rather than an antigentriggered, antibody secretion. Hormonal control of the common mucosal immune system has previously been demonstrated in both animals and humans. In the ovariectomized rat model, uterine IgA has been shown to be under the control of estradiol (46) . Likewise, in the mouse, progesterone, estrogen, and prolactin determine the ability of the mammary gland to trap IgA immunoblasts (42) . In humans, it is known that immunoglobulin localization within the mammary gland varies with the menstrual cycle (27) . sIgA antibodies to the polypeptide virulence plasmidencoded antigens of Shigella in human milk also persist throughout lactation (5, 6) . Because multiple epitopes exist in the virulence plasmid antigens, cross-reactions with environmental antigens are impossible to exclude. Because reactions to Shigella LPSs are unlikely to be induced by cross-reacting antigens, the demonstration of sIgA throughout lactation suggests that there exists a long-term memory in the secretory immune system for Shigella spp.
